BD active retraction safe vascular indwelling needle
Taiwan·Risk Class 2·BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.·Registered Oct 30, 2009 – Oct 30, 2029Active- Analysis ID
- 473b679736d67831dd7df03d73ebeb40
- Customs Code
- DHA00602028208
- Manufacturer
- BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
- Manufacturer Country
- United States
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- J General hospital and personal use equipment
- Product Type (Level 2)
- J.5200 Endovascular catheters
- Import Information
- import
- Registration Date
- Oct 30, 2009
- Expiry Date
- Oct 30, 2029
Top companies providing products similar to "BD active retraction safe vascular indwelling needle"
Recently registered similar products
Access comprehensive regulatory information for BD active retraction safe vascular indwelling needle in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 473b679736d67831dd7df03d73ebeb40 and manufactured by BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including BECTON DICKINSON INFUSION THERAPY SYSTEMS INC., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.